219 related articles for article (PubMed ID: 15699391)
1. Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation.
Quinzii CM; Kattah AG; Naini A; Akman HO; Mootha VK; DiMauro S; Hirano M
Neurology; 2005 Feb; 64(3):539-41. PubMed ID: 15699391
[TBL] [Abstract][Full Text] [Related]
2. Aprataxin gene mutations in Tunisian families.
Amouri R; Moreira MC; Zouari M; El Euch G; Barhoumi C; Kefi M; Belal S; Koenig M; Hentati F
Neurology; 2004 Sep; 63(5):928-9. PubMed ID: 15365154
[TBL] [Abstract][Full Text] [Related]
3. Clinical and molecular characterization of ataxia with oculomotor apraxia patients in Saudi Arabia.
Bohlega SA; Shinwari JM; Al Sharif LJ; Khalil DS; Alkhairallah TS; Al Tassan NA
BMC Med Genet; 2011 Feb; 12():27. PubMed ID: 21324166
[TBL] [Abstract][Full Text] [Related]
4. Early-onset ataxia with ocular motor apraxia and hypoalbuminemia: the aprataxin gene mutations.
Shimazaki H; Takiyama Y; Sakoe K; Ikeguchi K; Niijima K; Kaneko J; Namekawa M; Ogawa T; Date H; Tsuji S; Nakano I; Nishizawa M
Neurology; 2002 Aug; 59(4):590-5. PubMed ID: 12196655
[TBL] [Abstract][Full Text] [Related]
5. Ataxia with oculomotor apraxia type 1 in Southern Italy: late onset and variable phenotype.
Criscuolo C; Mancini P; Saccà F; De Michele G; Monticelli A; Santoro L; Scarano V; Banfi S; Filla A
Neurology; 2004 Dec; 63(11):2173-5. PubMed ID: 15596775
[TBL] [Abstract][Full Text] [Related]
6. Muscle coenzyme Q10 deficiencies in ataxia with oculomotor apraxia 1.
Le Ber I; Dubourg O; Benoist JF; Jardel C; Mochel F; Koenig M; Brice A; Lombès A; Dürr A
Neurology; 2007 Jan; 68(4):295-7. PubMed ID: 17242337
[TBL] [Abstract][Full Text] [Related]
7. Identification of a novel mutation in the
Inlora J; Sailani MR; Khodadadi H; Teymurinezhad A; Takahashi S; Bernstein JA; Garshasbi M; Snyder MP
Cold Spring Harb Mol Case Stud; 2017 Nov; 3(6):. PubMed ID: 28652255
[TBL] [Abstract][Full Text] [Related]
8. Ataxia with oculomotor apraxia type1 (AOA1): novel and recurrent aprataxin mutations, coenzyme Q10 analyses, and clinical findings in Italian patients.
Castellotti B; Mariotti C; Rimoldi M; Fancellu R; Plumari M; Caimi S; Uziel G; Nardocci N; Moroni I; Zorzi G; Pareyson D; Di Bella D; Di Donato S; Taroni F; Gellera C
Neurogenetics; 2011 Aug; 12(3):193-201. PubMed ID: 21465257
[TBL] [Abstract][Full Text] [Related]
9. A novel mutation in the aprataxin (APTX) gene in an Iranian individual suffering early-onset ataxia with oculomotor apraxia type 1(AOA1) disease.
Nouri N; Nouri N; Aryani O; Kamalidehghan B; Sedghi M; Houshmand M
Iran Biomed J; 2012; 16(4):223-5. PubMed ID: 23183622
[TBL] [Abstract][Full Text] [Related]
10. Early-onset ataxia with ocular motor apraxia and hypoalbuminemia/ataxia with oculomotor apraxia 1.
Tada M; Yokoseki A; Sato T; Makifuchi T; Onodera O
Adv Exp Med Biol; 2010; 685():21-33. PubMed ID: 20687492
[TBL] [Abstract][Full Text] [Related]
11. A novel mutation of aprataxin associated with ataxia ocular apraxia type 1: phenotypical and genotypical characterization.
Ferrarini M; Squintani G; Cavallaro T; Ferrari S; Rizzuto N; Fabrizi GM
J Neurol Sci; 2007 Sep; 260(1-2):219-24. PubMed ID: 17572444
[TBL] [Abstract][Full Text] [Related]
12. Clinical, Biomarker, and Molecular Delineations and Genotype-Phenotype Correlations of Ataxia With Oculomotor Apraxia Type 1.
Renaud M; Moreira MC; Ben Monga B; Rodriguez D; Debs R; Charles P; Chaouch M; Ferrat F; Laurencin C; Vercueil L; Mallaret M; M'Zahem A; Pacha LA; Tazir M; Tilikete C; Ollagnon E; Ochsner F; Kuntzer T; Jung HH; Beis JM; Netter JC; Djamshidian A; Bower M; Bottani A; Walsh R; Murphy S; Reiley T; Bieth É; Roelens F; Poll-The BT; Lourenço CM; Jardim LB; Straussberg R; Landrieu P; Roze E; Thobois S; Pouget J; Guissart C; Goizet C; Dürr A; Tranchant C; Koenig M; Anheim M
JAMA Neurol; 2018 Apr; 75(4):495-502. PubMed ID: 29356829
[TBL] [Abstract][Full Text] [Related]
13. A novel nonsense mutation in the APTX gene associated with delayed DNA single-strand break removal fails to enhance sensitivity to different genotoxic agents.
Crimella C; Cantoni O; Guidarelli A; Vantaggiato C; Martinuzzi A; Fiorani M; Azzolini C; Orso G; Bresolin N; Bassi MT
Hum Mutat; 2011 Apr; 32(4):E2118-33. PubMed ID: 21412945
[TBL] [Abstract][Full Text] [Related]
14. Aprataxin mutations are a rare cause of early onset ataxia in Germany.
Habeck M; Zühlke C; Bentele KH; Unkelbach S; Kress W; Bürk K; Schwinger E; Hellenbroich Y
J Neurol; 2004 May; 251(5):591-4. PubMed ID: 15164193
[TBL] [Abstract][Full Text] [Related]
15. Complete APTX deletion in a patient with ataxia with oculomotor apraxia type 1.
van Minkelen R; Guitart M; Escofet C; Yoon G; Elfferich P; Bolman GM; van der Helm R; van de Graaf R; van den Ouweland AM
BMC Med Genet; 2015 Aug; 16():61. PubMed ID: 26285866
[TBL] [Abstract][Full Text] [Related]
16. Lack of aprataxin impairs mitochondrial functions via downregulation of the APE1/NRF1/NRF2 pathway.
Garcia-Diaz B; Barca E; Balreira A; Lopez LC; Tadesse S; Krishna S; Naini A; Mariotti C; Castellotti B; Quinzii CM
Hum Mol Genet; 2015 Aug; 24(16):4516-29. PubMed ID: 25976310
[TBL] [Abstract][Full Text] [Related]
17. Ataxia with Ocular Apraxia Type 1 (AOA1) (APTX, W279* Mutation): Neurological, Neuropsychological, and Molecular Outlining of a Heterogenous Phenotype in Four Colombian Siblings.
Aguillon D; Vasquez D; Madrigal L; Moreno S; Hernández D; Isaza-Ruget M; Lopez JJ; Landires I; Nuñez-Samudio V; Restrepo CM; Vidal OM; Vélez JI; Arcos-Holzinger M; Lopera F; Arcos-Burgos M
Mol Neurobiol; 2022 Jun; 59(6):3845-3858. PubMed ID: 35420381
[TBL] [Abstract][Full Text] [Related]
18. Complex Movement Disorders in Ataxia with Oculomotor Apraxia Type 1: Beyond the Cerebellar Syndrome.
Pedroso JL; Vale TC; da Costa SCG; Santos M; Alonso I; Barsottini OGP
Tremor Other Hyperkinet Mov (N Y); 2020 Oct; 10():39. PubMed ID: 33101765
[TBL] [Abstract][Full Text] [Related]
19. Early-onset ataxia with oculomotor apraxia with a novel APTX mutation.
Ito A; Yamagata T; Mori M; Momoi MY
Pediatr Neurol; 2005 Jul; 33(1):53-6. PubMed ID: 15876520
[TBL] [Abstract][Full Text] [Related]
20. Primary Coenzyme Q deficiency Due to Novel ADCK3 Variants, Studies in Fibroblasts and Review of Literature.
Shalata A; Edery M; Habib C; Genizi J; Mahroum M; Khalaily L; Assaf N; Segal I; Abed El Rahim H; Shapira H; Urian D; Tzur S; Douiev L; Saada A
Neurochem Res; 2019 Oct; 44(10):2372-2384. PubMed ID: 30968303
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
